Paper36298564
The Epidemiological Features of the SARS-CoV-2 Omicron Subvariant BA.5 and Its Evasion of the Neutralizing Activity of Vaccination and Prior Infection.
Tian D and 3 others. Vaccines (Basel), 2022. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. The Epidemiological Features of the SARS-CoV-2 Omicron Subvariant BA.5 and Its Evasion of the Neutralizing Activity of Vaccination and Prior Infection. Papers, record 36298564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36298564
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Epidemiological Features of the SARS-CoV-2 Omicron Subvariant BA.5 and Its Evasion of the Neutralizing Activity of Vaccination and Prior Infection.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35474907 | SARS-CoV-2 mutations acquired during serial passage in human cell lines are consistent with several of those found in recent natural SARS-CoV-2 variants. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/35474907 | PubMed |
| 2 | 34166623 | Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species. | Immunity | 2021 | https://conductscience.org/library/papers/34166623 | PubMed |
| 3 | 35871089 | In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5. | Sci Rep | 2022 | https://conductscience.org/library/papers/35871089 | PubMed |
| 4 | 33735608 | SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. | Cell | 2021 | https://conductscience.org/library/papers/33735608 | PubMed |
| 5 | 32571838 | A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. | Science | 2020 | https://conductscience.org/library/papers/32571838 | PubMed |
| 6 | 34754982 | Analysis of SARS-COV2 spike protein variants among Iraqi isolates. | Gene Rep | 2022 | https://conductscience.org/library/papers/34754982 | PubMed |
| 7 | 36436752 | Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa. | Int J Infect Dis | 2023 | https://conductscience.org/library/papers/36436752 | PubMed |
| 8 | 35714668 | BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. | Nature | 2022 | https://conductscience.org/library/papers/35714668 | PubMed |
| 9 | 35853878 | Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35853878 | PubMed |
| 10 | 33853970 | Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. | Science | 2021 | https://conductscience.org/library/papers/33853970 | PubMed |
| 11 | 35750920 | What Omicron's BA.4 and BA.5 variants mean for the pandemic. | Nature | 2022 | https://conductscience.org/library/papers/35750920 | PubMed |
| 12 | 36379191 | Persistent Laplacian projected Omicron BA.4 and BA.5 to become new dominating variants. | Comput Biol Med | 2022 | https://conductscience.org/library/papers/36379191 | PubMed |
| 13 | 35731894 | Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35731894 | PubMed |
| 14 | 35484110 | SARS-CoV-2 Omicron variant: recent progress and future perspectives. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35484110 | PubMed |
| 15 | 35118687 | The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. | J Med Virol | 2022 | https://conductscience.org/library/papers/35118687 | PubMed |
| 16 | 35264324 | Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. | BMJ | 2022 | https://conductscience.org/library/papers/35264324 | PubMed |
| 17 | 35690075 | Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/35690075 | PubMed |
| 18 | 35772405 | Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. | Cell | 2022 | https://conductscience.org/library/papers/35772405 | PubMed |
| 19 | 35777385 | Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/35777385 | PubMed |
| 20 | 35770368 | The emergence of Omicron lineages BA.4 and BA.5, and the global spreading trend. | J Med Virol | 2022 | https://conductscience.org/library/papers/35770368 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42079734 | Genomic insights into SARS-CoV-2 evolution in Yantai, China after the adjustment of the dynamic zero-COVID policy in 2023. | PeerJ | 2026 | https://conductscience.org/library/papers/42079734 | PubMed |
| 40369416 | In-depth analysis of the risk factors for persistent severe acute respiratory syndrome coronavirus 2 infection and construction of predictive models: an exploratory research study. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/40369416 | PubMed |
| 39443934 | Oral complications during the two waves of COVID-19 pandemic in China: a prospective cross-section analysis of 510 cases using questionnaire. | BMC Oral Health | 2024 | https://conductscience.org/library/papers/39443934 | PubMed |
| 38587722 | Analysis of SARS-CoV-2 omicron mutations that emerged during long-term replication in a lung cancer xenograft mouse model. | Virus Genes | 2024 | https://conductscience.org/library/papers/38587722 | PubMed |
| 38263035 | The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in Macao. | Chin Med | 2024 | https://conductscience.org/library/papers/38263035 | PubMed |
| 38257736 | Susceptibility and Resistance of SARS-CoV-2 Variants to LCB1 and Its Multivalent Derivatives. | Viruses | 2023 | https://conductscience.org/library/papers/38257736 | PubMed |
| 38169898 | Effect of second booster vaccination on clinical outcomes of Omicron-variant breakthrough infection: A propensity score matching cohort study. | Heliyon | 2024 | https://conductscience.org/library/papers/38169898 | PubMed |
| 38156316 | An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/38156316 | PubMed |
| 38003257 | Comparative Computational Analysis of Spike Protein Structural Stability in SARS-CoV-2 Omicron Subvariants. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003257 | PubMed |
| 37954618 | SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience. | Front Immunol | 2023 | https://conductscience.org/library/papers/37954618 | PubMed |
| 37645409 | Clinical characteristics and acute complication of COVID-19 patients with diabetes: a multicenter, retrospective study in Southern China. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37645409 | PubMed |
| 37553605 | Differences in clinical characteristics and liver injury between patients diagnosed with the Omicron subvariant BA.5.2 and the prototype of SARS-CoV-2: a single center retrospective study. | BMC Gastroenterol | 2023 | https://conductscience.org/library/papers/37553605 | PubMed |
| 37444682 | One Pandemic, Two Solutions: Comparing the U.S.-China Response and Health Priorities to COVID-19 from the Perspective of "Two Types of Control". | Healthcare (Basel) | 2023 | https://conductscience.org/library/papers/37444682 | PubMed |
| 37243100 | Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37243100 | PubMed |
| 36851526 | Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity. | Viruses | 2023 | https://conductscience.org/library/papers/36851526 | PubMed |
| 36704960 | Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China. | Hum Vaccin Immunother | 2023 | https://conductscience.org/library/papers/36704960 | PubMed |
| 36641977 | Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study. | Phytomedicine | 2023 | https://conductscience.org/library/papers/36641977 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| TMED2 | 10959 | PubTator's text mining | https://conductscience.org/library/genes/10959 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36298564
GET https://conductscience.org/api/papers/v1/36298564/references?page=2